Concourse Financial Group Securities, Inc. Bio Techne Corp Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
27 transactions
Others Institutions Holding TECH
# of Institutions
613Shares Held
161MCall Options Held
225KPut Options Held
80.8K-
Vanguard Group Inc Valley Forge, PA18.4MShares$1.17 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$951 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.85MShares$561 Million0.05% of portfolio
-
Morgan Stanley New York, NY6.58MShares$417 Million0.02% of portfolio
-
State Street Corp Boston, MA5.86MShares$372 Million0.01% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.49B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...